{
  "case_id": "Case_5",
  "model_id": "liquid/lfm-40b",
  "content": "{\n    \"primary_diagnosis\": {\n        \"name\": \"Parkinson's disease\",\n        \"confidence\": 0.8,\n        \"icd_code\": \"G20\",\n        \"reasoning\": \"The patient's symptoms of tremor, bradykinesia, and rigidity are classic for Parkinson's disease, and the absence of family history aligns with sporadic Parkinson's disease onset. The subtle signal abnormalities in basal ganglia on MRI support this diagnosis.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Post-infectious Parkinsonism\",\n            \"confidence\": 0.3,\n            \"icd_code\": \"Unknown\",\n            \"reasoning\": \"Recent travel to rural Bangladesh and symptoms starting 6 months after return suggest a possible link to infectious agents, but this is less likely given the progressive nature of symptoms and MRI findings.\"\n        },\n        {\n            \"name\": \"Drug-induced Parkinsonism\",\n            \"confidence\": 0.2,\n            \"icd_code\": \"E89.1\",\n            \"reasoning\": \"While less likely given the patient's history, it remains a consideration. However, no history of medication known to cause Parkinsonism is mentioned.\"\n        },\n        {\n            \"name\": \"Wilson's disease\",\n            \"confidence\": 0.1,\n            \"icd_code\": \"E83.5\",\n            \"reasoning\": \"Recent work on water purification may have exposed the patient to copper or other metals, but this is highly speculative and less likely given the progressive nature of symptoms and MRI findings.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Progressive neurological symptoms\",\n        \"Subtle signal abnormalities in basal ganglia on MRI\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"DaTscan\",\n            \"purpose\": \"To confirm dopaminergic deficit\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"24-hour urine copper\",\n            \"purpose\": \"To rule out Wilson's disease\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Comprehensive metabolic panel\",\n            \"purpose\": \"To assess for systemic diseases\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Start levodopa-carbidopa 25mg/100mg twice daily\",\n            \"Recommend occupational therapy\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Levodopa-carbidopa\",\n                \"dose\": \"25mg/100mg twice daily\",\n                \"route\": \"PO\",\n                \"duration\": \"Until further notice\",\n                \"rationale\": \"To improve motor symptoms of Parkinson's disease\"\n            }\n        ],\n        \"monitoring\": [\n            \"Motor symptoms, dyskinesia\",\n            \"Every 3 months\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Movement Disorders\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"For further management and rehabilitation\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Rapid progression of symptoms\",\n        \"Recent fever or infection\"\n    ],\n    \"patient_education\": [\n        \"Parkinson's disease is a progressive neurological disorder\",\n        \"Medications can improve symptoms but do not cure the disease\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"In 1 month\",\n        \"conditions\": \"Rapid symptom worsening or new neurological symptoms\"\n    },\n    \"confidence_in_assessment\": 0.8,\n    \"uncertainties\": [\n        \"Exact etiology of Parkinson's disease\",\n        \"Impact of environmental exposure on symptoms\"\n    ]\n}\n\n",
  "latency": 8.0849130153656,
  "timestamp": "2025-08-10T01:22:09.107363",
  "cached_at": "2025-08-10T01:22:09.107367"
}